Skip to main content
Prepainted

Kamen Rider Zeztz - Rider Hero Series - Esprim Recovery (Bandai)

Kamen Rider Zeztz from Kamen Rider Zeztz

0 collectors wished this · Find on marketplace

Height140 mm
First releaseSep 2025
ManufacturerBandai
𝕏 ShareFacebook⊞ SimilarItem #4249
0Comments
18Views
Figure file

About this figure

This Kamen Rider Zeztz figure is part of Bandai's Rider Hero Series, specifically the Esprim Recovery version. The Rider Hero Series is Bandai's long-running line of articulated figures depicting characters from the Kamen Rider franchise, one of Japan's most iconic tokusatsu series produced by Toei. Kamen Rider Zeztz represents a installment in the franchise, with the Esprim Recovery version depicting a specific form or transformation state of the character. The Kamen Rider franchise has been a cornerstone of Japanese tokusatsu entertainment since its debut, featuring motorcycle-riding heroes who transform to battle evil organizations and monsters. Each Kamen Rider series introduces new characters, forms, and storylines, with Bandai's Rider Hero Series providing accessible collectible figures of the various riders and their different forms. The Esprim Recovery version represents a particular story element or transformation from the Kamen Rider Zeztz narrative. The figure stands approximately 140mm tall and is produced by Bandai. As part of the Rider Hero Series, it offers collectors an articulated representation of Kamen Rider Zeztz in the Esprim Recovery form, suitable for display and posing.

Classification
Prepainted
Dimensions
H 140 mm
Edition history

Releases 1 edition(s)

Every printing of this item, newest first. Prices are manufacturer list; aftermarket varies — see offers below.

Sep 2025StandardLatest
JAN 4582769807244 asStandard (Japan)
¥NaN
From collectors' shelves

Pictures 2

Kamen Rider Zeztz - Rider Hero Series - Esprim Recovery (Bandai) photo 1
Kamen Rider Zeztz - Rider Hero Series - Esprim Recovery (Bandai) photo 2
Discussion

Comments 0

Be kind. Spoilers behind tags.Sign in to comment

Sign in to join the discussion.